Post-approval studies (Phase 4)Study completedNCT03154515
What this trial is testing
Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults
Who this might be right for
Common ColdInfluenza, HumanAcute Respiratory Infection
Valenta Pharm JSC 445